Analysing the Effects of Xingnaojing for Mild-to-severe Acute Ischemic Stroke
Status:
Not yet recruiting
Trial end date:
2021-08-28
Target enrollment:
Participant gender:
Summary
The main purpose of this trial is to analyse the Effects of Xingnaojing for Mild-to-severe
Acute Ischemic Stroke by Metabonomics, proteomics and clinical parameters.
Phase:
N/A
Details
Lead Sponsor:
Dongzhimen Hospital, Beijing
Collaborators:
Affiliated Hospital of Chengde Medical University Nanjing Brian Hospital Nantong University